Texas 2023 88th Regular

Texas House Bill HB1190 House Committee Report / Fiscal Note

Download
.pdf .doc .html
                    LEGISLATIVE BUDGET BOARD     Austin, Texas       FISCAL NOTE, 88TH LEGISLATIVE REGULAR SESSION             April 28, 2023       TO: Honorable Stephanie Klick, Chair, House Committee on Public Health     FROM: Jerry McGinty, Director, Legislative Budget Board      IN RE: HB1190 by Klick (relating to the prescribing and ordering of Schedule II controlled substances by certain advanced practice registered nurses and physician assistants.), Committee Report 1st House, Substituted     No significant fiscal implication to the State is anticipated. Based on the information provided by the Texas Medical Board, the Health and Human Services Commission, the Board of Pharmacy, and the Department of State Health Services, duties and responsibilities associated with implementing the bill's provisions could be accomplished by utilizing existing resources.  Local Government ImpactNo significant fiscal implication to units of local government is anticipated.  Source Agencies: b > td > 503 Texas Medical Board, 507 Texas Board of Nursing, 515 Board of Pharmacy, 529 Health and Human Services Commission, 537 State Health Services, Department of  LBB Staff: b > td > JMc, NPe, BFa

LEGISLATIVE BUDGET BOARD
Austin, Texas
FISCAL NOTE, 88TH LEGISLATIVE REGULAR SESSION
April 28, 2023

 

 

  TO: Honorable Stephanie Klick, Chair, House Committee on Public Health     FROM: Jerry McGinty, Director, Legislative Budget Board      IN RE: HB1190 by Klick (relating to the prescribing and ordering of Schedule II controlled substances by certain advanced practice registered nurses and physician assistants.), Committee Report 1st House, Substituted   

TO: Honorable Stephanie Klick, Chair, House Committee on Public Health
FROM: Jerry McGinty, Director, Legislative Budget Board
IN RE: HB1190 by Klick (relating to the prescribing and ordering of Schedule II controlled substances by certain advanced practice registered nurses and physician assistants.), Committee Report 1st House, Substituted

 Honorable Stephanie Klick, Chair, House Committee on Public Health

 Honorable Stephanie Klick, Chair, House Committee on Public Health

 Jerry McGinty, Director, Legislative Budget Board 

 Jerry McGinty, Director, Legislative Budget Board 

 HB1190 by Klick (relating to the prescribing and ordering of Schedule II controlled substances by certain advanced practice registered nurses and physician assistants.), Committee Report 1st House, Substituted 

 HB1190 by Klick (relating to the prescribing and ordering of Schedule II controlled substances by certain advanced practice registered nurses and physician assistants.), Committee Report 1st House, Substituted 



No significant fiscal implication to the State is anticipated.

No significant fiscal implication to the State is anticipated.

Based on the information provided by the Texas Medical Board, the Health and Human Services Commission, the Board of Pharmacy, and the Department of State Health Services, duties and responsibilities associated with implementing the bill's provisions could be accomplished by utilizing existing resources.

 Local Government Impact

No significant fiscal implication to units of local government is anticipated.

Source Agencies: b > td > 503 Texas Medical Board, 507 Texas Board of Nursing, 515 Board of Pharmacy, 529 Health and Human Services Commission, 537 State Health Services, Department of

503 Texas Medical Board, 507 Texas Board of Nursing, 515 Board of Pharmacy, 529 Health and Human Services Commission, 537 State Health Services, Department of

LBB Staff: b > td > JMc, NPe, BFa

JMc, NPe, BFa